Tim is an investment advisor representative in Atlanta, GA. He has been an active investor in the life sciences since the mid-1990’s. His interest originated with research coverage of a private equity investment of Cambridge, MA based Ariad Pharmaceuticals (acquired in 2017 by Takeda for $5.2 billion), while working at a small family office/hedge fund, during that period.
His enthusiasm grew in the years since the financial crisis, as easy monetary policy provided ample liquidity to fund biotechnology research at exactly the time when digital advances would accelerate the pace and efficacy of that research.
Tim resides in Atlanta, with his eight year old grandson, Oliver, where he also manages Asymmetric Capital Advisory. Tim earned a BA in Economics and History from Williams College and a Masters in Accounting from NYU Stern School of Business.